BR112013010958A8 - Métodos para elevar a solubilidade de compostos pouco solúveis e métodos para fabricação e para uso de formulações de tais compostos - Google Patents
Métodos para elevar a solubilidade de compostos pouco solúveis e métodos para fabricação e para uso de formulações de tais compostosInfo
- Publication number
- BR112013010958A8 BR112013010958A8 BR112013010958A BR112013010958A BR112013010958A8 BR 112013010958 A8 BR112013010958 A8 BR 112013010958A8 BR 112013010958 A BR112013010958 A BR 112013010958A BR 112013010958 A BR112013010958 A BR 112013010958A BR 112013010958 A8 BR112013010958 A8 BR 112013010958A8
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- present
- formulations
- compounds
- relates
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 2
- 229930003935 flavonoid Natural products 0.000 abstract 6
- 150000002215 flavonoids Chemical class 0.000 abstract 6
- 235000017173 flavonoids Nutrition 0.000 abstract 6
- 238000009472 formulation Methods 0.000 abstract 5
- 150000002894 organic compounds Chemical class 0.000 abstract 3
- 239000012141 concentrate Substances 0.000 abstract 2
- 239000008135 aqueous vehicle Substances 0.000 abstract 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/652—The particulate/core comprising organic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
COMPOSIÇÕES COMPREENDENDO CONCENTRADO DE COMPOSTO ORGÂNICO E MÉTODOS PARA PREPARAR CONCENTRADO DE FLAVONOIDE SOLUBILIZADO, PARA ELEVAR A SOLUBILIDADE DE UM FLAVONOIDE EM UM VEÍCULO AQUOSO E PARA PREPARAR UM POLIFENOL SOLUBILIZADO. A presente invenção refere-se a formas solúveis de compostos orgânicos com estrutura de anel planar, incluindo flavonoides, e a sua produção. A presente invenção também se refere ao uso destas formas de compostos orgânicos com estrutura de anel planar na preparação de formulações e produtos. A presente invenção também se refere a uma ampla variedade de aplicações das formulações da invenção. A presente invenção refere-se a formas solúveis e várias formulações de flavonoides. Além disso, a presente invenção refere-se a métodos para a fabricação das formulações de flavonoides. A presente invenção também se refere a uma ampla variedade de aplicações das formulações de flavonoides.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2010/002821 WO2011049629A2 (en) | 2009-10-22 | 2010-10-22 | Methods of making and using compositions comprising flavonoids |
| US13/064,882 US8637569B2 (en) | 2009-10-22 | 2011-04-22 | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| PCT/US2011/001802 WO2012054090A1 (en) | 2010-10-22 | 2011-10-24 | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013010958A2 BR112013010958A2 (pt) | 2016-08-30 |
| BR112013010958A8 true BR112013010958A8 (pt) | 2017-10-03 |
Family
ID=48222436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013010958A BR112013010958A8 (pt) | 2010-10-22 | 2011-10-24 | Métodos para elevar a solubilidade de compostos pouco solúveis e métodos para fabricação e para uso de formulações de tais compostos |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP2629763B1 (pt) |
| JP (1) | JP6105475B2 (pt) |
| KR (1) | KR101817635B1 (pt) |
| CN (1) | CN103327971A (pt) |
| AU (3) | AU2011318580B2 (pt) |
| BR (1) | BR112013010958A8 (pt) |
| CA (1) | CA2815321C (pt) |
| WO (1) | WO2012054090A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| CN102711743A (zh) | 2009-10-22 | 2012-10-03 | Api起源有限责任公司 | 含有黄酮类的组合物的制备和使用方法 |
| US9731015B2 (en) | 2012-08-04 | 2017-08-15 | Eric Hauser Kuhrts | Water-soluble lipophilic natural compound formulations |
| AU2013341380B2 (en) * | 2012-11-12 | 2018-04-26 | Propella Therapeutics, Inc. | Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid |
| KR20150080342A (ko) * | 2013-12-31 | 2015-07-09 | 삼성정밀화학 주식회사 | 기능성 음료 |
| EP3100744A4 (en) * | 2014-01-29 | 2017-08-30 | Nitto Denko Corporation | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation |
| KR20160106181A (ko) * | 2014-01-29 | 2016-09-09 | 닛토덴코 가부시키가이샤 | 피부 투과 촉진 조성물, 경피 투여 제제 및 첩부 제제 |
| US20190046481A1 (en) * | 2015-09-18 | 2019-02-14 | Delivra Inc. | Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions |
| CN112915076B (zh) * | 2016-06-15 | 2022-11-08 | 南京简庄生物技术有限公司 | 一种外用皮肤组织保护及修复制剂 |
| KR20190049752A (ko) * | 2016-08-24 | 2019-05-09 | 댓 큐. 트란 | 식용 거품 용액용 제제 |
| CN106588848B (zh) * | 2016-11-15 | 2019-10-18 | 浙江工业大学 | 一种花生壳中提取木犀草素的方法 |
| CN107096034B (zh) * | 2017-04-27 | 2020-03-31 | 重庆医科大学 | 一种载芹菜素透明质酸靶向纳米组装体及其制备方法 |
| EP3866750A4 (en) * | 2018-10-17 | 2022-07-27 | Austin Research Labs Corp. | SUSPENSION FORMULATIONS OF HIGH LOAD DISPERSIONS |
| CN111717931A (zh) * | 2019-03-20 | 2020-09-29 | 华东理工大学 | 一种二氧化钛多孔微球的制备方法 |
| WO2020205539A1 (en) * | 2019-03-29 | 2020-10-08 | Vizuri Health Sciences Consumer Healthcare, Inc. | Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers |
| KR102372213B1 (ko) | 2019-09-09 | 2022-03-08 | 한국화학연구원 | 히알루론산 또는 그의 염 및 폴리페놀 화합물을 포함하는 수분해성 필름 |
| FR3134973A1 (fr) * | 2022-04-28 | 2023-11-03 | L'oreal | Composition de maquillage comprenant un polyphénol, un composé polyoxyalkyléné ou polyglycérolé, un monoalcool et un acide carboxylique hydroxylé, et procédé la mettant en œuvre |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4506046A (en) * | 1983-05-27 | 1985-03-19 | General Electric Company | Flame retardant polycarbonate compositions |
| US4603046A (en) * | 1985-08-23 | 1986-07-29 | Charles Of The Ritz Group Ltd. | Improved sunscreen or sunblock composition |
| DE19647352C2 (de) | 1996-11-15 | 2000-06-29 | Aqua Nova Getraenketechnologie | Nicht alkoholisches Getränk mit einem Gehalt an Q 10 |
| JP4006133B2 (ja) * | 1999-05-17 | 2007-11-14 | 松谷化学工業株式会社 | 可溶性イソフラボン組成物及びその製造方法 |
| DE10103454A1 (de) * | 2000-12-29 | 2002-08-01 | Aquanova Getraenketechnologie | Wirkstoffkonzentrate sowie Verfahren zu ihrer Herstellung |
| ATE425743T1 (de) * | 2001-02-11 | 2009-04-15 | Aquanova Ag | Verfahren zur herstellung eines isoflavon- konzentrats |
| DE10129973A1 (de) * | 2001-06-21 | 2003-01-02 | Beiersdorf Ag | Kosmetische oder dermatologische getränkte Tücher |
| AU2003240300A1 (en) | 2002-06-25 | 2004-01-06 | Cosmeceutic Solutions Pty Ltd | Topical cosmetic compositions |
| DE10260872B4 (de) * | 2002-12-23 | 2013-09-26 | Beiersdorf Ag | Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices |
| WO2004069233A1 (ja) * | 2003-02-04 | 2004-08-19 | Kabushiki Kaisha Yakult Honsha | 乳癌耐性蛋白阻害剤 |
| CN1761450B (zh) * | 2003-02-13 | 2010-05-05 | 株式会社林原生物化学研究所 | 特征在于含有α,α-海藻糖的糖类衍生物的皮肤外用剂 |
| US20040229825A1 (en) | 2003-05-13 | 2004-11-18 | Tomihiko Higuchi | Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant |
| KR100437274B1 (ko) | 2003-10-15 | 2004-06-24 | 주식회사 케이엠에스아이 | 연골재생제로서 아피제닌을 함유하는 골관절염 치료 조성물 |
| WO2005087182A1 (ja) * | 2004-03-17 | 2005-09-22 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 機能性粉体 |
| WO2006014629A2 (en) | 2004-07-20 | 2006-02-09 | Hillcrest Laboratories, Inc. | Graphical cursor navigation methods |
| US20060021625A1 (en) | 2004-07-30 | 2006-02-02 | Philip Morris Usa Inc. | Make-your-own smoking article with controlled burn rate |
| US7329797B2 (en) | 2004-12-08 | 2008-02-12 | Ceres, Inc. | Modulating plant carbon levels |
| US20060067905A1 (en) | 2005-04-01 | 2006-03-30 | Sederma Sas | Formulations and method for treating baldness |
| US20080220102A1 (en) * | 2005-07-08 | 2008-09-11 | Dariush Behnam | Solubilsation Products of an Active Ingredient Extract |
| US7664355B2 (en) | 2006-02-14 | 2010-02-16 | Coveytech Llc | All-optical gates using nonlinear elements-claim set III |
| CN101951768A (zh) | 2007-02-14 | 2011-01-19 | 玛尔斯有限公司 | 神经原性化合物 |
| JP5000373B2 (ja) * | 2007-04-27 | 2012-08-15 | 東洋精糖株式会社 | 水溶性フラボノイド組成物およびその製造方法、ならびに水溶性フラボノイド組成物を含む食品等 |
| FR2933871B1 (fr) * | 2008-07-18 | 2012-12-14 | Yvery | Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe |
| AU2009329025A1 (en) * | 2008-11-17 | 2010-06-24 | Laila Pharmaceuticals Pvt. Ltd. | A process for nanoemulsification of curcumin and derivatives of curcumin |
| KR20110096132A (ko) * | 2008-11-26 | 2011-08-29 | 리포프로틴 테크놀로지스, 인코포레이티드 | 레스베라트롤의 향상된 생활성 제제 |
| CN101518262B (zh) * | 2009-03-20 | 2011-08-17 | 温州医学院 | 一种促进兰花菌根共生体形成的诱导剂组合物及其制备方法 |
-
2011
- 2011-10-24 KR KR1020177011182A patent/KR101817635B1/ko active IP Right Grant
- 2011-10-24 BR BR112013010958A patent/BR112013010958A8/pt not_active Application Discontinuation
- 2011-10-24 EP EP11788238.1A patent/EP2629763B1/en active Active
- 2011-10-24 CA CA2815321A patent/CA2815321C/en active Active
- 2011-10-24 AU AU2011318580A patent/AU2011318580B2/en active Active
- 2011-10-24 JP JP2013534896A patent/JP6105475B2/ja active Active
- 2011-10-24 WO PCT/US2011/001802 patent/WO2012054090A1/en active Application Filing
- 2011-10-24 EP EP17199056.7A patent/EP3345594B1/en active Active
- 2011-10-24 CN CN2011800621798A patent/CN103327971A/zh active Pending
-
2016
- 2016-04-06 AU AU2016202145A patent/AU2016202145B2/en active Active
-
2018
- 2018-01-04 AU AU2018200079A patent/AU2018200079B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6105475B2 (ja) | 2017-03-29 |
| WO2012054090A1 (en) | 2012-04-26 |
| EP2629763A1 (en) | 2013-08-28 |
| CA2815321A1 (en) | 2012-04-26 |
| CN103327971A (zh) | 2013-09-25 |
| KR101817635B1 (ko) | 2018-01-11 |
| AU2016202145B2 (en) | 2017-10-05 |
| AU2018200079A1 (en) | 2018-01-25 |
| CA2815321C (en) | 2018-10-16 |
| AU2011318580A1 (en) | 2013-05-09 |
| AU2011318580B2 (en) | 2016-01-07 |
| EP3345594A1 (en) | 2018-07-11 |
| AU2016202145A1 (en) | 2016-04-28 |
| EP2629763B1 (en) | 2017-12-06 |
| JP2013541557A (ja) | 2013-11-14 |
| AU2018200079B2 (en) | 2018-10-04 |
| KR20170049619A (ko) | 2017-05-10 |
| BR112013010958A2 (pt) | 2016-08-30 |
| EP3345594B1 (en) | 2021-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013010958A8 (pt) | Métodos para elevar a solubilidade de compostos pouco solúveis e métodos para fabricação e para uso de formulações de tais compostos | |
| BR112012011336A2 (pt) | Composições compreendendo flavonoides, seu método de preparação, adesivo para aplicação de flavonoide, métodos de produção de flavonoide hidratado,métodos de preparação de formulação tópica, e uso de flavonoide | |
| ECSP23088864A (es) | Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso | |
| WO2013016257A8 (en) | Botanical antioxidant compositions and methods of preparation and use thereof | |
| PA8660301A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion | |
| CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| BR112015000615A8 (pt) | Purinas macrocíclicas para o tratamento de infecções virais e composição farmacêutica que as compreende | |
| BR122019021714B8 (pt) | preparação compreendendo vitamina b12 e butanol e butafosfano, e seu uso | |
| CL2011002451A1 (es) | Composicion que comprende al menos un flavonoide util para preparar producto que suministran una incrementada biodisponibilidad de hesperetina. uso de dicha composicion. | |
| UY31942A (es) | Formulaciones de adyuvante comprendiendo combinaciones de triterpenoides, esteroles, inmunomoduladores, polímeros y estimuladores de th2, procedimientos de preparación, composiciones y aplicaciones. | |
| CL2011003021A1 (es) | Uso de una mezcla de procianidinas oligomericas y acido ascorbico o analogos para mejorar la biodisponibilidad de dicha catequina. | |
| CO6920294A2 (es) | Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
| WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
| UY29416A1 (es) | Derivados de ácido pirimidincarboxílico y su uso | |
| ES2408343R1 (es) | Composiciones farmacéuticas que comprenden hidromorfona y naloxona | |
| HN2010001537A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| BR112015010703A8 (pt) | Uso de uma composição farmacêutica e composição farmacêutica | |
| BR112012009310A2 (pt) | composto, e, composição farmacêutica | |
| WO2015019193A3 (en) | Acylated derivatives of phloridzin and isoquercetrin as anticancer therapeutics and methods of use thereof | |
| MX363530B (es) | Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo. | |
| BR112016000092A2 (pt) | nanopartículas lipídicas para a cicatrização de feridas | |
| ECSP20023535A (es) | Nuevos derivados macrocíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| GT200600048A (es) | Pirroles sustituidos, composiciones que los contienen, proceso de fabricación y utilización. | |
| BR112015000163A2 (pt) | composição; procedimento para a preparação da composição; poliamidas de moldagem; procedimento para a preparação de poliamidas de moldagem; e uso da composição | |
| WO2015071299A3 (en) | Stable pharmaceutical glycylcycline compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: VIZURI HEALTH SCIENCES LLC (US) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |